VBI Vaccines Inc. (VBIV)

Finanzdaten der VBI Vaccines Inc.-Aktie (VBIV)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	820.00% 6.624	0.72	0.485	0.293	0.317
Operating Expenses	55.71% 16.69	37.69	19.99	21.73	21.88
Interest Income/Expense	9.66% 1.543	1.708	1.429	1.208	0.958
Benefits Costs and Expenses	40.31% 27.07	45.35	28.24	21.43	25.53
Costs And Expenses	40.31% 27.07	45.35	28.24	21.43	25.53
Operating Income/Loss	72.77% -10.07	-36.97	-19.51	-21.44	-21.56
Income/Loss From Continuing Operations Before Tax	54.19% -20.44	-44.63	-27.75	-21.14	-25.21
Income/Loss From Continuing Operations After Tax	54.19% -20.44	-44.63	-27.75	-21.14	-25.21
Net Income/Loss	54.19% -20.44	-44.63	-27.75	-21.14	-25.21
Preferred Stock Dividends And Other Adjustments	0.862	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	145.88% 21.17	8.6085	8.6085	0.000067	258.26
Diluted Average Shares	145.88% 21.17	8.6085	-	-	-
Basic Earnings Per Share	80.50% -1.01	-5.18	-3.22	-0.08	-0.10
Diluted Earnings Per Share	80.50% -1.01	-5.18	-3.23	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	0.862	-	-	-	-